, Nov. 21, 2013
/PRNewswire/ -- Absorption Pharmaceuticals (AP), the innovators behind Promescent, announced today the addition of three new experts to their national sales and support team to better cater to its growing demand from urologists and pharmacies. Word of Promescent's superior efficacy, minimal side effects, ease-of-use, and low cost per dose for treating premature ejaculation is spreading fast, so in an effort to solidify continued success and satisfaction, the company has recruited some of the most knowledgeable and qualified salespersons in the field to join their team.
"Only 9% of men with PE seek help from their physician, so there's a lack of knowledge among patients and many urologists with the causes and latest treatment options for PE," says Jeff Abraham, CEO of Absorption Pharmaceuticals. "It's critical that our sales and service team have the experience in sexual medicine to efficiently educate physicians, PAs, and pharmacists."
Lisa Waddington joins AP as the director of Eastern U.S. regional sales, based in New York City. She comes to AP from Bryce Rx Laboratories, one of the nation's compounding-only pharmacies, which specialized in erectile dysfunction. Lisa developed Bryce Rx's distribution of advanced ED medications, including Trimix, with hundreds of urologists across the United States.
Victoria Skrip joins AP as the director of Midwest U.S. regional sales, based in Chicago. Prior to AP, she was an award-winning urology and women's health care representative for Warner Chilcott Pharmaceuticals, based in Louisville, Kentucky.
Mary Ann Adkins joins AP as the director of physician services, based in Las Vegas. Mary Ann has extensive experience in sexual medicine, particularly with solutions following radical prostatectomy to help men regain sexual function. She understands the physician, PA, and administrative staff goals for patient care and will bring that perspective to AP.
"I'm excited to add Lisa, Victoria and Mary Ann to the team," concludes Abraham. "Not only do they provide additional geographic coverage, but each of them provides new knowledge in the field of sexual medicine that strengthens the company's ability to serve both patient and physician."
Already, there are more than one thousand urologists across the U.S. currently using Promescent as first-line treatment for premature ejaculation, and its popularity is now also surging among sex therapists and even general practitioners. With three sterling new additions to their sales force, Absorption Pharmaceuticals can now extend their aid and reach even further.
About Absorption Pharmaceuticals
Absorption Pharmaceuticals is the maker of Promescent, an FDA-approved, topical medication for premature ejaculation. Many key opinion leaders in sexual medicine consider Promescent the leading solution for premature ejaculation in the U.S. The California-based company has been featured in numerous media including CNBC, NBC News, Dr. Oz, the Doctors, CNN and the National Post. Learn more at www.promescent.com.
For more information, or to purchase Promescent, please visit https://www.promescent.com/.
SOURCE Absorption Pharmaceuticals